September 26, 2015
Data Safety Monitoring Board Recommends Continuation of Nexstim Plc’s Phase III Stroke Therapy Trial
Media
September 24, 2015
CERAMENT™ Antibiotic Eluting Bone Substitutes For The Management Of Osteomyelitis Prominent At The 34th Annual Meeting Of The European Bone & Joint Infection Society (EBJIS)
September 18, 2015
New regulations will expand access to treatment of opioid dependence in the US
September 17, 2015
SAVE THE DATE: NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO, NORWAY ON 17 NOVEMBER 2015
September 17, 2015
Cerenis Therapeutics is joining the Euronext indexes CAC® Small, CAC® Mid & Small and CAC® All-Tradable
September 15, 2015
Strongbridge Biopharma plc Announces Appointment of Garheng Kong, M.D., Ph.D., MBA, to its Board of Directors
September 14, 2015
Targovax appoints two new directors to its board
September 10, 2015
AMRA, BerGenBio and Nexstim receive Nordic Stars 2015 Awards at NLSDays in Stockholm
September 08, 2015
First patients enter phase II CARAT trial to assess reduction in atherosclerotic plaque using CER-001 in post Acute Coronary Syndrome (ACS) patients
September 04, 2015
Cerenis Therapeutics announces the publication of positive preclinical data in the world-renowned scientific journal PLOS ONE
